517 related articles for article (PubMed ID: 18330889)
21. High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC, TP53, K-RAS, and BRAF genes with a novel DHPLC fluorescence detection platform.
Lilleberg SL; Durocher J; Sanders C; Walters K; Culver K
Ann N Y Acad Sci; 2004 Jun; 1022():250-6. PubMed ID: 15251969
[TBL] [Abstract][Full Text] [Related]
22. Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression.
Shahrzad S; Quayle L; Stone C; Plumb C; Shirasawa S; Rak JW; Coomber BL
Cancer Res; 2005 Sep; 65(18):8134-41. PubMed ID: 16166287
[TBL] [Abstract][Full Text] [Related]
23. [p53 mutations in sporadic colorectal cancers with microsatellite instability].
Huang J; Zheng S; Pan QR; Deng YC
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1130-3. PubMed ID: 12921629
[TBL] [Abstract][Full Text] [Related]
24. Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy.
Hongyo T; Buzard GS; Palli D; Weghorst CM; Amorosi A; Galli M; Caporaso NE; Fraumeni JF; Rice JM
Cancer Res; 1995 Jun; 55(12):2665-72. PubMed ID: 7780983
[TBL] [Abstract][Full Text] [Related]
25. Microsatellite instability and K-ras mutations in patients with ulcerative colitis.
Lyda MH; Noffsinger A; Belli J; Fenoglio-Preiser CM
Hum Pathol; 2000 Jun; 31(6):665-71. PubMed ID: 10872658
[TBL] [Abstract][Full Text] [Related]
26. K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy.
Etienne-Grimaldi MC; Formento JL; Francoual M; François E; Formento P; Renée N; Laurent-Puig P; Chazal M; Benchimol D; Delpero JR; Letoublon C; Pezet D; Seitz JF; Milano G
Clin Cancer Res; 2008 Aug; 14(15):4830-5. PubMed ID: 18676755
[TBL] [Abstract][Full Text] [Related]
27. Laser pressure catapulting (LPC): optimization LPC-system and genotyping of colorectal carcinomas.
Bazan V; La Rocca G; Corsale S; Agnese V; Macaluso M; Migliavacca M; Gregorio V; Cascio S; Sisto PS; Di Fede G; Buscemi M; Fiorentino E; Passantino R; Morello V; Tomasino RM; Russo A
J Cell Physiol; 2005 Feb; 202(2):503-9. PubMed ID: 15316933
[TBL] [Abstract][Full Text] [Related]
28. Distinct K-ras mutation pattern characterizes signet ring cell colorectal carcinoma.
Wistuba II; Behrens C; Albores-Saavedra J; Delgado R; Lopez F; Gazdar AF
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3615-9. PubMed ID: 14506148
[TBL] [Abstract][Full Text] [Related]
29. Characterization of p53 mutations in colorectal liver metastases and correlation with clinical parameters.
Tullo A; D'Erchia AM; Honda K; Mitry RR; Kelly MD; Habib NA; Saccone C; Sbisà E
Clin Cancer Res; 1999 Nov; 5(11):3523-8. PubMed ID: 10589767
[TBL] [Abstract][Full Text] [Related]
30. [Familial colorectal cancer type X: clinical, pathological and molecular characterization].
Ferreira S; Lage P; Sousa R; Claro I; Francisco I; Filipe B; Suspiro A; Chaves P; Rodrigues P; Albuquerque C; Nobre Leitão C
Acta Med Port; 2009; 22(3):207-14. PubMed ID: 19686620
[TBL] [Abstract][Full Text] [Related]
31. P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma.
Elsaleh H; Powell B; McCaul K; Grieu F; Grant R; Joseph D; Iacopetta B
Clin Cancer Res; 2001 May; 7(5):1343-9. PubMed ID: 11350904
[TBL] [Abstract][Full Text] [Related]
32. K-ras codon 12 mutation determines the polypoid growth of colorectral cancer.
Chiang JM; Chou YH; Chou TB
Cancer Res; 1998 Aug; 58(15):3289-93. PubMed ID: 9699657
[TBL] [Abstract][Full Text] [Related]
33. K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients.
Zhu D; Keohavong P; Finkelstein SD; Swalsky P; Bakker A; Weissfeld J; Srivastava S; Whiteside TL
Cancer Res; 1997 Jun; 57(12):2485-92. PubMed ID: 9192830
[TBL] [Abstract][Full Text] [Related]
34. Genetic alterations in K-ras and p53 cancer genes in lung neoplasms from Swiss (CD-1) male mice exposed transplacentally to AZT.
Hong HH; Dunnick J; Herbert R; Devereux TR; Kim Y; Sills RC
Environ Mol Mutagen; 2007; 48(3-4):299-306. PubMed ID: 16395694
[TBL] [Abstract][Full Text] [Related]
35. P14 methylation in human colon cancer is associated with microsatellite instability and wild-type p53.
Shen L; Kondo Y; Hamilton SR; Rashid A; Issa JP
Gastroenterology; 2003 Mar; 124(3):626-33. PubMed ID: 12612901
[TBL] [Abstract][Full Text] [Related]
36. Ki-ras mutation type and the survival benefit from adjuvant chemotherapy in Dukes' C colorectal cancer.
Gnanasampanthan G; Elsaleh H; McCaul K; Iacopetta B
J Pathol; 2001 Dec; 195(5):543-8. PubMed ID: 11745689
[TBL] [Abstract][Full Text] [Related]
37. Unusual profile and high prevalence of p53 mutations in esophageal squamous cell carcinomas from northern Iran.
Biramijamal F; Allameh A; Mirbod P; Groene HJ; Koomagi R; Hollstein M
Cancer Res; 2001 Apr; 61(7):3119-23. PubMed ID: 11306496
[TBL] [Abstract][Full Text] [Related]
38. Mucinous carcinomas of the colorectum have distinct molecular genetic characteristics.
Song GA; Deng G; Bell I; Kakar S; Sleisenger MH; Kim YS
Int J Oncol; 2005 Mar; 26(3):745-50. PubMed ID: 15703832
[TBL] [Abstract][Full Text] [Related]
39. Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer.
Smith G; Carey FA; Beattie J; Wilkie MJ; Lightfoot TJ; Coxhead J; Garner RC; Steele RJ; Wolf CR
Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9433-8. PubMed ID: 12093899
[TBL] [Abstract][Full Text] [Related]
40. Microsatellite instability and MBD4 mutation in unselected colorectal cancer.
Evertson S; Wallin A; Arbman G; Rütten S; Emterling A; Zhang H; Sun XF
Anticancer Res; 2003; 23(4):3569-74. PubMed ID: 12926109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
